Dr Stephen Watt  - Director of Screening

Stephen was previously at the Pfizer Institute at the University of Cambridge where he worked on amorphous materials.  From there he progressed to a CRO providing screening and co-crystal formation services, and then was employed in the physical properties group at GSK, where he was responsible for selecting the best physical form to move into development.

As Director of Screening he is drawing on all his past experiences and leading Pharmaterials forward in the salt selection, polymorphism and co-crystal fields.